Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurotech North America is a U.S. medical device company focused on non-invasive electrotherapy systems for rehabilitation, muscle re-education, and pain management. Its marketed products include devices such as Kneehab XP, Neurotech Plus, and Neurotech Recovery-Back, which use neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation to support orthopedic and spine recovery. The business appears to operate primarily as a commercial-stage device supplier rather than a drug-development biotech company. Neurotech North America was formerly part of BioMedical Research Group and was acquired by Theragen, after which it has been described as a wholly owned subsidiary of Theragen. The company serves healthcare providers and patients in the United States with drug-free, home-usable rehabilitation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurotech North America.